Effectiveness, immunogenicity, and safety of influenza vaccines with MF59 adjuvant in healthy people of different age groups: a systematic review and meta-analysis
J Yang, J Zhang, T Han, C Liu, X Li, L Yan, B Yang… - Medicine, 2020 - journals.lww.com
J Yang, J Zhang, T Han, C Liu, X Li, L Yan, B Yang, X Yang
Medicine, 2020•journals.lww.comBackground: Influenza is a severe disease burden among all age groups. This study aimed
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non-
adjuvanted inactivated influenza vaccines among all age groups against specific influenza
vaccine strains. Methods: Literature search of PubMed, Embase, Medline, OVID, and
Cochrane Library Trials (CENTRAL) was implemented up to March 1, 2019. Homogeneity
qualified studies were included for
to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non-
adjuvanted inactivated influenza vaccines among all age groups against specific influenza
vaccine strains. Methods: Literature search of PubMed, Embase, Medline, OVID, and
Cochrane Library Trials (CENTRAL) was implemented up to March 1, 2019. Homogeneity
qualified studies were included for
Abstract
Background:
Influenza is a severe disease burden among all age groups. This study aimed to review the efficacy of inactivated influenza vaccines with MF59 adjuvant and non-adjuvanted inactivated influenza vaccines among all age groups against specific influenza vaccine strains.
Methods:
Literature search of PubMed, Embase, Medline, OVID, and Cochrane Library Trials (CENTRAL) was implemented up to March 1, 2019. Homogeneity qualified studies were included for
Lippincott Williams & Wilkins